HVTN 105 Study: Monitoring HIV-Specific Antibody and T-Cell Responses

HVTN 105 Study: Monitoring HIV-Specific Antibody and T-Cell Responses

Oct 4, 2019 | DNA Vaccine, Emory University School of Medicine, HIV, HIV-Specific Antibodies, Protein Vaccines, University of Rochester Medical Center, Vaccines

Randomized DNA and protein vaccines were administered in four randomized treatment groups to determine which strategy would induce favorable HIV-specific antibody and T-cell responses. The study was led by Nadine Rouphael, MD, protocol co-chair and Investigator at the...

Pin It on Pinterest